| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.0096 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.032 |
0.9 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.9 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.0061 |
0.9 |